Bertram Pitt Selected Research

benazepril (Briem)

1/2018	Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
7/2013	Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.
2/2013	Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
4/2012	Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
3/2012	Renal outcomes in hypertensive Black patients at high cardiovascular risk.
2/2011	Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
6/2010	Cardiovascular events during differing hypertension therapies in patients with diabetes.
4/2010	Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
10/2009	Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension.
12/2008	Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bertram Pitt Research Topics

Disease

238	Heart Failure 09/2022 - 01/2002
71	Myocardial Infarction 04/2022 - 04/2002
48	Hyperkalemia 01/2022 - 04/2003
46	Chronic Renal Insufficiency 04/2022 - 03/2010
43	Hypertension (High Blood Pressure) 10/2021 - 10/2003
42	Left Ventricular Dysfunction 04/2022 - 12/2002
29	Type 2 Diabetes Mellitus (MODY) 04/2022 - 01/2005
18	Systolic Heart Failure 01/2021 - 01/2006
15	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 10/2002
14	Renal Insufficiency (Renal Failure) 02/2022 - 01/2001
14	Isolated Systolic Hypertension 01/2018 - 09/2004
13	Albuminuria 04/2022 - 10/2003
13	Respiratory Sounds (Crackle) 01/2022 - 01/2002
13	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 07/2015
13	Fibrosis (Cirrhosis) 01/2022 - 09/2003
13	Diabetes Mellitus 01/2021 - 06/2005
13	Hypokalemia 01/2020 - 04/2003
10	Stroke (Strokes) 01/2022 - 01/2007
10	Heart Arrest (Cardiac Arrest) 11/2021 - 04/2014
9	Disease Progression 01/2022 - 01/2017
9	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2019 - 08/2005
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 12/2003
7	Kidney Diseases (Kidney Disease) 04/2022 - 09/2004
7	Atrial Fibrillation 04/2022 - 05/2012
7	Inflammation (Inflammations) 01/2022 - 09/2003
7	Acute Coronary Syndrome 09/2015 - 07/2004
6	ST Elevation Myocardial Infarction 02/2020 - 03/2014
5	Cardiomyopathies (Cardiomyopathy) 09/2022 - 04/2002
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 06/2004
5	Hypotension (Low Blood Pressure) 01/2021 - 04/2010
4	Chronic Kidney Failure (Chronic Renal Failure) 02/2014 - 01/2009
4	Infarction (Infarctions) 02/2014 - 03/2004
4	Ventricular Remodeling 03/2013 - 12/2002
4	Hypertrophy 01/2013 - 12/2002
3	COVID-19 01/2022 - 12/2020
3	Essential Hypertension 01/2022 - 10/2003
3	Infections 05/2021 - 12/2020
3	Sudden Death 11/2018 - 06/2006
3	Heart Diseases (Heart Disease) 01/2018 - 02/2007
3	Coronary Disease (Coronary Heart Disease) 11/2015 - 01/2004

Drug/Important Bio-Agent (IBA)

108	Mineralocorticoid Receptor AntagonistsIBA 02/2022 - 05/2002
70	Eplerenone (Inspra)FDA LinkGeneric 04/2022 - 04/2002
51	PotassiumIBA 01/2022 - 03/2003
48	Spironolactone (Aldactone)FDA LinkGeneric 04/2022 - 01/2002
42	AldosteroneIBA 12/2020 - 04/2002
27	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2002
26	CreatinineIBA 01/2022 - 03/2003
22	finerenoneIBA 04/2022 - 06/2012
18	DiureticsIBA 04/2022 - 01/2002
17	Pharmaceutical PreparationsIBA 01/2022 - 01/2001
17	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2006
16	patiromerIBA 01/2022 - 04/2011
16	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2002
15	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 09/2004
13	Amlodipine (Norvasc)FDA LinkGeneric 01/2018 - 10/2002
12	SodiumIBA 09/2022 - 02/2017
12	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 05/2002
12	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 09/2004
11	AlbuminsIBA 01/2022 - 07/2011
11	benazepril (Briem)FDA LinkGeneric 01/2018 - 09/2004
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 05/2008
8	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 06/2012
8	Natriuretic PeptidesIBA 09/2022 - 10/2015
7	pro-brain natriuretic peptide (1-76)IBA 09/2022 - 07/2010
7	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 08/2021 - 12/2002
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2020 - 01/2002
7	AngiotensinsIBA 12/2020 - 03/2003
7	Valsartan (Vals)FDA Link 01/2020 - 01/2007
7	Digoxin (Digitek)FDA LinkGeneric 01/2019 - 01/2002
7	CollagenIBA 12/2018 - 12/2002
6	Insulin (Novolin)FDA Link 01/2022 - 04/2012
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2013 - 01/2001
5	ReninIBA 12/2020 - 02/2009
5	Irbesartan FDA LinkGeneric 01/2020 - 01/2017
5	PolymersIBA 05/2018 - 04/2011
5	LipidsIBA 02/2013 - 01/2006
4	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2022 - 01/2021
4	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2021
4	Furosemide (Lasix)FDA LinkGeneric 01/2021 - 03/2015
4	candesartanIBA 01/2020 - 03/2004
4	Enalapril FDA LinkGeneric 01/2020 - 10/2003
4	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 01/2003
4	Angiotensin IIIBA 01/2018 - 10/2003
4	Valsartan Drug Combination Amlodipine FDA Link 01/2014 - 01/2011
4	aliskiren FDA Link 08/2011 - 05/2008
3	dapagliflozinIBA 09/2022 - 10/2019
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
3	KBP-5074IBA 10/2021 - 01/2020
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2021 - 02/2008
3	Torsemide (Demadex)FDA LinkGeneric 01/2021 - 06/2009
3	Collagen Type III (Type III Collagen)IBA 01/2021 - 02/2020
3	Hemoglobins (Hemoglobin)IBA 11/2020 - 05/2018
3	flosequinanIBA 01/2017 - 11/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 01/2004
3	ThiazidesIBA 02/2013 - 01/2008

Therapy/Procedure

95	Therapeutics 09/2022 - 01/2002
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2014 - 01/2004
4	Percutaneous Coronary Intervention 06/2014 - 01/2007
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2019 - 01/2018
3	Patient Readmission 09/2014 - 05/2006